We are live on ! Find out more
P

&Partners Portfolio holdings

AUM $20.2B
1-Year Est. Return 19.79%
This Fund
S&P 500
This Quarter Est. Return
+2.61%
1 Year Est. Return
+19.79%
3 Year Est. Return
+62.7%
5 Year Est. Return
+67.16%
10 Year Est. Return
AUM
$19.1B
AUM Growth
+$3.5B
Cap. Flow
+$3.21B
Cap. Flow %
16.8%
Top 10 Hldgs %
22.78%
Holding
2,377
New
257
Increased
1,417
Reduced
565
Closed
95

Sector Composition

Rank Sector Weight
1 Technology 18.06%
2 Financials 8.71%
3 Healthcare 5.74%
4 Industrials 5.3%
5 Consumer Discretionary 4.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELTX icon
2201
Elicio Therapeutics
ELTX
$78.8M
$79.6K ﹤0.01%
10,000
RGP icon
2202
Resources Connection
RGP
$129M
$77K ﹤0.01%
+15,270
New +$72.8K
HIO
2203
Western Asset High Income Opportunity Fund
HIO
$335M
$74.4K ﹤0.01%
20,046
+650
+3% +$2.46K
OBE
2204
Obsidian Energy
OBE
$707M
$73.7K ﹤0.01%
12,021
-2,062
-15% -$12.5K
TSI
2205
TCW Strategic Income Fund
TSI
$212M
$70.9K ﹤0.01%
+14,349
New +$70.7K
ABEV icon
2206
Ambev
ABEV
$47.3B
$67.7K ﹤0.01%
27,390
+7,590
+38% +$18.1K
BRBS icon
2207
Blue Ridge Bankshares
BRBS
$311M
$67.1K ﹤0.01%
+15,723
New +$68.2K
OFS icon
2208
OFS Capital
OFS
$43.8M
$64.3K ﹤0.01%
13,500
PLUG icon
2209
Plug Power
PLUG
$2.92B
$59.9K ﹤0.01%
30,428
+9,244
+44% +$24.1K
NAK
2210
Northern Dynasty Minerals
NAK
$885M
$59.1K ﹤0.01%
30,000
SLDP icon
2211
Solid Power
SLDP
$468M
$57.3K ﹤0.01%
13,475
-9,025
-40% -$49.8K
CRBU icon
2212
Caribou Biosciences
CRBU
$156M
$56.5K ﹤0.01%
35,505
-8,634
-20% -$18.1K
ALT icon
2213
Altimmune
ALT
$539M
$54.3K ﹤0.01%
+15,035
New +$65.5K
CIK
2214
Credit Suisse Asset Management Income Fund
CIK
$133M
$44.4K ﹤0.01%
15,700
VVR icon
2215
Invesco Senior Income Trust
VVR
$456M
$36.6K ﹤0.01%
11,197
-23,139
-67% -$76.4K
SABR icon
2216
Sabre
SABR
$656M
$35.7K ﹤0.01%
27,207
+1,370
+5% +$2.36K
ABCL icon
2217
AbCellera Biologics
ABCL
$1.62B
$34.2K ﹤0.01%
10,000
-5,000
-33% -$22.3K
FSP
2218
Franklin Street Properties
FSP
$44.8M
$28.8K ﹤0.01%
30,405
-5,405
-15% -$6.28K
ATOS icon
2219
Atossa Therapeutics
ATOS
$22.8M
$25.4K ﹤0.01%
+2,867
New +$36.3K
FBLG icon
2220
FibroBiologics
FBLG
$4.33M
$22.5K ﹤0.01%
5,000
UONEK icon
2221
Urban One Class D
UONEK
$22.9M
$9.46K ﹤0.01%
+1,101
New +$8.04K
DEFT
2222
Defi Technologies
DEFT
$153M
$8.56K ﹤0.01%
11,350
ACM icon
2223
Aecom
ACM
$9.07B
-3,077
Closed -$401K
ACU icon
2224
Acme United Corp
ACU
$206M
-5,354
Closed -$220K
BAH icon
2225
Booz Allen Hamilton
BAH
$8.7B
-4,299
Closed -$430K

Similar funds

&Partners's Q4 2025 Portfolio in Review

As of Q4 2025, &Partners held 2,377 positions worth $19.1B, up 22% from $15.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

&Partners deployed $3.21B of net new capital in Q4 2025, opening 257 new positions and adding to 1,417 existing holdings. Its largest new stake was Nomura Focused Emerging Markets Equity ETF: 316,469 shares worth $12.7M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 1000 ETF, an estimated $11.7M trimmed.

  • &Partners's largest Q4 2025 buy was Nomura Focused Emerging Markets Equity ETF: 316,469 shares worth $12.7M.
  • &Partners added most to Apple in Q4 2025, an estimated $126M increase.
  • &Partners's biggest Q4 2025 reduction was iShares Russell 1000 ETF, cutting an estimated $11.7M.
  • &Partners fully exited Invesco BulletShares 2025 Corporate Bond ETF in Q4 2025, selling an estimated $1.69M.
  • &Partners's ten largest holdings make up 23% of its $19.1B portfolio in Q4 2025.
  • &Partners opened 257 new positions and closed 95 in Q4 2025.
  • &Partners's portfolio value rose 22% quarter-over-quarter to $19.1B.

Based on &Partners's 13F filing for Q4 2025, filed 17 Feb 2026.